| ACT | Adoptive cell therapy |
| TIL | Tumor-Infiltrating Lymphocyte |
| TCR | T-Cell Receptor |
| CAR | Chimeric Antigen Receptor |
| hiPSC-CMs | human-induced pluripotent stem cell-derived cardiomyocytes |
| CTLA-4 | Cytotoxic T-lymphocyte-associated antigen 4 |
| ASE | American Society of Echocardiography |
| EACVI | European Association of Cardiovascular Imaging |
| IRAEs | Immune-related adverse events |
| IMARs | Immune-related adverse reactions |
| ICI | Immune checkpoint inhibitors |
| LVD | Left ventricular dysfunction |
| HFpEF | Heart failure with preserved ejection fraction |
| PD-1 | Programmed cell death protein-1 |
| PD-L1 | Programmed death ligand-1 |